Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
40 hedge funds and large institutions have $58.2M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
42% more capital invested
Capital invested by funds: $40.9M → $58.2M (+$17.3M)
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
11% more funds holding
Funds holding: 36 → 40 (+4)
68% less call options, than puts
Call options by funds: $168K | Put options by funds: $525K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SR
Summer Road
West Palm Beach,
Florida
|
+$11.2M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.43M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$890K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$557K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$176K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.47M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.06M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$844K |
| 4 |
Renaissance Technologies
New York
|
-$314K |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$278K |
CORV Hedge Fund Activity: Q1 2019 in Review
40 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2019, worth a combined $58.2M — up 42% from $40.9M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CORV positions and 4 closed out — a net gain of 4 holders — while 12 added to existing stakes and 9 trimmed.
The largest buyer was Summer Road, opening a new position worth an estimated $11.2M. The largest seller was Putnam Investments, cutting an estimated $5.47M.
- 40 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2019, up from 36 in Q4 2018.
- Funds reported $58.2M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2019, up 42% quarter-over-quarter.
- 8 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2019 and 4 closed out, a net change of +4 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2019 was Summer Road, an estimated $11.2M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2019 was Putnam Investments, an estimated $5.47M sold.
Based on aggregated 13F filings for Q1 2019.